Freia Krause

This study shows that ADAM10's non-catalytic function, not its enzymatic activity, regulates hepatic progenitor cell fate and liver regeneration.

This study shows ADAM17 on myeloid cells drives hepatic DNA damage repair and tumour formation in HCC, suggesting it as a therapeutic target.